ArisGlobal Releases New Version of Its Unified Electronic Data Capture System
agCapture 3.2 Delivers on the Promise of Real Unification of Data Management Processes
“Trial sponsors are constantly searching for ways to reduce study costs and improve efficiencies while adhering to compliance requirements,” stated Simon Sparkes, executive vice president, ArisGlobal. “agCapture is simply a stand-out EDC system that is not only unified with our advanced ePro, RTSM and IWRS solutions, but is now fully integrated with CTMS using CDISC ODM (Clinical Data Interchange Standards Consortium Operational Data Model) standards as the basis of the integration. There is quite simply no other clinical drug development platform to match the ArisGlobal eClinical solution suite.”
agCapture 3.2 delivers many key features and enhancements that ensure a successful clinical study:
- Greater flexibility and adaptability: While agCapture can support paper studies, study teams can now also easily create hybrid studies that combine both manual double data entry (DDE) and EDC. Sites can be specified as an EDC site or a traditional paper as required.
- Staging areas: Streamlines the study design process by supporting different design phases, making it easier to validate changes and manage the change control process even after a study is live.
- Advanced study builder: Users can easily create studies using standard CRF templates, optimizing the study setup time, design and validation process. This provides real benefits such as reducing study build time, standardizing the study design, achieving full data consolidation instantly and eliminating training.
- EDC to CTMS integration: Relevant status data is automatically transmitted from a company’s EDC system to their CTMS, triggering key activities such as investigator payments and monitoring visits. The transfer of data such as trial, visit, subject and CRF statuses, along with subject-specific identifiers is exchanged between the two modules using the CDISC- ODM standards.
- SAML-enabled solution: agCapture is also now a SAML-enabled (Security Assertion Markup Language) solution that supports single- sign-on, providing simplified access to data across multiple applications.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025